(RTTNews) - Evotec SE (EVTG.DE, EVTCY.PK, EVO), a German healthcare company, announced preliminary results for the first nine months of 2026 that came in above market expectations, while reaffirming its fiscal 2026 guidance.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.